Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | GRM5 | P41594 | 14/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31272842 | 1.00 | KDM4E (0.43) | KDM4EALDH1A1MAPTTSHRHTT | |
| SCHEMBL23341614 | 0.96 | KDM4E (0.40) | KDM4EALDH1A1MAPTTSHRHTT | |
| SCHEMBL31272615 | 0.95 | KDM4E (0.43) | KDM4EALDH1A1MAPTTSHRHTT | |
| SCHEMBL31400268 | 0.90 | GRM5 (0.39) | KDM4EALDH1A1MAPTTSHRHTT | |
| SCHEMBL31273647 | 0.86 | GRM5 (0.40) | KDM4EALDH1A1MAPTTSHRHTT | |
| SCHEMBL31273342 | 0.85 | SMN1; SMN2 (0.40) | KDM4EALDH1A1MAPTTSHRHTT | |
| SCHEMBL31272441 | 0.84 | ADORA1 (0.38) | KDM4EGRM5 | |
| SCHEMBL31272881 | 0.83 | TGFBR1 (0.35) | KDM4EALDH1A1MAPTTSHRHTT | |
| SCHEMBL31273483 | 0.83 | GRM5 (0.38) | KDM4EALDH1A1MAPTTSHRHTT | |
| SCHEMBL22454895 | 0.82 | GRM5 (0.44) | KDM4EALDH1A1MAPTTSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210135119-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210135119-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | KDM4E 4364/4885ALDH1A1 242/4885MAPT 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.